<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD00510000_2</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P67870</UniProt_ID>
  <Seq_Length>215</Seq_Length>
  <Molecule_Weight>24942</Molecule_Weight>
  <KEGG_ID>hsa:1460</KEGG_ID>
  <Orthology_ID>K03115</Orthology_ID>
  <EBI_ID>EBI-348169</EBI_ID>
  <Function_Summary>Participates in Wnt signaling (By similarity). Plays a complex role in regulating the basal catalytic activity of the alpha subunit.</Function_Summary>
  <Pfam_ID>PF01214:CK_II_beta</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>5</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Casein kinase II subunit beta</Alias>
      <Alias>The Ser/Thr kinase CK2</Alias>
      <Alias>Casein kinase 2</Alias>
      <Alias>CK II beta</Alias>
      <Alias>Protein kinase CK2</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.</Detail>
      <Keyword>Receptor binding</Keyword>
      <Ontology_ID>GO:0005102</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a specific domain of a protein.</Detail>
      <Keyword>Protein domain specific binding</Keyword>
      <Ontology_ID>GO:0019904</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an identical protein or proteins.</Detail>
      <Keyword>Identical protein binding</Keyword>
      <Ontology_ID>GO:0042802</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Modulates the activity of a protein kinase, an enzyme which phosphorylates a protein.</Detail>
      <Keyword>Protein kinase regulator activity</Keyword>
      <Ontology_ID>GO:0019887</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription.</Detail>
      <Keyword>Transcription factor binding</Keyword>
      <Ontology_ID>GO:0008134</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.</Detail>
      <Keyword>Positive regulation of pathway-restricted SMAD protein phosphorylation</Keyword>
      <Ontology_ID>GO:0010862</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.</Detail>
      <Keyword>Axon guidance</Keyword>
      <Ontology_ID>GO:0007411</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The aggregation, arrangement and bonding together of a set of components to form a protein complex, occurring at the level of an individual cell.</Detail>
      <Keyword>Cellular protein complex assembly</Keyword>
      <Ontology_ID>GO:0043623</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which the anatomical structures of a tube are generated and organized from an endothelium. An endothelium is an epithelium that lines an anatomical structure.</Detail>
      <Keyword>Endothelial tube morphogenesis</Keyword>
      <Ontology_ID>GO:0061154</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the migration of the endothelial cells of blood vessels.</Detail>
      <Keyword>Negative regulation of blood vessel endothelial cell migration</Keyword>
      <Ontology_ID>GO:0043537</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular signals generated as a consequence of adiponectin binding to a cell surface receptor.</Detail>
      <Keyword>Adiponectin-mediated signaling pathway</Keyword>
      <Ontology_ID>GO:0033211</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents or reduces the rate or extent of cell proliferation.</Detail>
      <Keyword>Negative regulation of cell proliferation</Keyword>
      <Ontology_ID>GO:0008285</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).</Detail>
      <Keyword>Regulation of DNA binding</Keyword>
      <Ontology_ID>GO:0051101</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the activity of any activin receptor signaling pathway.</Detail>
      <Keyword>Positive regulation of activin receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0032927</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.</Detail>
      <Keyword>Wnt receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0016055</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>212</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>3</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>8</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>209</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>197</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>145</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>69</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>205</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>4</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MSSSEEVSWISWFCGLRGNEFFCEVDEDYIQDKFNLTGLNEQVPHYRQALDMILDLEPDEELEDNPNQSDLIEQAAEMLYGLIHARYILTNRGIAQMLEKYQQGDFGYCPRVYCENQPMLPIGLSDIPGEAMVKLYCPKCMDVYTPKSSRHHHTDGAYFGTGFPHMLFMVHPEYRPKRPANQFVPRLYGFKIHPMAYQLQLQAASNFKSPVKTIR</Protein_Seq>
    <DNA_Seq>ACTCCCCCCACCCCACTTCGCCTGCCGCGGTCGGGTCCGCGGCCTGCGCTGTAGCGGTCGCCGCCGTTCCCTGGAAGTAGCAACTTCCCTACCCCACCCCAGTCCTGGTCCCCGTCCAGCCGCTGACGTGAAGATGAGCAGCTCAGAGGAGGTGTCCTGGATTTCCTGGTTCTGTGGGCTCCGTGGCAATGAATTCTTCTGTGAAGTGGATGAAGACTACATCCAGGACAAATTTAATCTTACTGGACTCAATGAGCAGGTCCCTCACTATCGACAAGCTCTAGACATGATCTTGGACCTGGAGCCTGATGAAGAACTGGAAGACAACCCCAACCAGAGTGACCTGATTGAGCAGGCAGCCGAGATGCTTTATGGATTGATCCACGCCCGCTACATCCTTACCAACCGTGGCATCGCCCAGATGTTGGAAAAGTACCAGCAAGGAGACTTTGGTTACTGTCCTCGTGTGTACTGTGAGAACCAGCCAATGCTTCCCATTGGCCTTTCAGACATCCCAGGTGAAGCCATGGTGAAGCTCTACTGCCCCAAGTGCATGGATGTGTACACACCCAAGTCATCAAGACACCATCACACGGATGGCGCCTACTTCGGCACTGGTTTCCCTCACATGCTCTTCATGGTGCATCCCGAGTACCGGCCCAAGAGACCTGCCAACCAGTTTGTGCCCAGGCTCTACGGTTTCAAGATCCATCCGATGGCCTACCAGCTGCAGCTCCAAGCCGCCAGCAACTTCAAGAGCCCAGTCAAGACGATTCGCTGATTCCCTCCCCCACCTGTCCTGCAGTCTTTGACTTTTCCTTTCTTTTTTGCCACCCTTTCAGGAACCCTGTATGGTTTTTAGTTTAAATTAAAGGAGTCGTTATTGTGGTGGGAATATGAAATAAAGTAGAAGAAAAGGCC</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>CSNK2B</Gene_Name>
    <Gene_Alias>CK2N; G5A</Gene_Alias>
    <Gene_ID>1460</Gene_ID>
    <Genbank_ACCN>NM_001320</Genbank_ACCN>
    <Protein_ACCN>NP_001311</Protein_ACCN>
    <HGNC_ID>2460</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/1460</Gene_URL>
    <UCSC_ID>uc003nvr.1</UCSC_ID>
    <EMBL_ID>ENSG00000204435</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P19784</Uniprot_ID>
      <Gene_Name>CSNK2A2</Gene_Name>
      <EBI_ID>EBI-347451</EBI_ID>
      <PPI_EBI_URL>EBI-348169,EBI-347451</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P67870</Uniprot_ID>
      <Gene_Name>CSNK2B</Gene_Name>
      <EBI_ID>EBI-348169</EBI_ID>
      <PPI_EBI_URL>EBI-348169,EBI-348169</PPI_EBI_URL>
      <Experiment_Number>6</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P68400</Uniprot_ID>
      <Gene_Name>CSNK2A1</Gene_Name>
      <EBI_ID>EBI-347804</EBI_ID>
      <PPI_EBI_URL>EBI-348169,EBI-347804</PPI_EBI_URL>
      <Experiment_Number>10</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O00257-3</Uniprot_ID>
      <Gene_Name>CBX4</Gene_Name>
      <EBI_ID>EBI-4392727</EBI_ID>
      <PPI_EBI_URL>EBI-348169,EBI-4392727</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Egg Allergy</Disease_Name>
      <Disease_Detail>Egg Allergy</Disease_Detail>
      <Disease_DB>EGG001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/egg_allergy?search=CSNK2B#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal Structure of Human Protein Kinase CK2 Holoenzyme</PDB_Title>
      <PDB_ID>1JWH</PDB_ID>
      <Resolution>3.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1JWH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme.</PubMed_Title>
      <Author>Niefind K, et al.</Author>
      <Journal>EMBO J. 2001 Oct 1;20(19):5320-31.</Journal>
      <PubMed_ID>11574463</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>TRUNCATED FORM OF CASEIN KINASE II BETA SUBUNIT (2-182) FROM HOMO SAPIENS</PDB_Title>
      <PDB_ID>1QF8</PDB_ID>
      <Resolution>1.74</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QF8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the human protein kinase CK2 regulatory subunit reveals its zinc finger-mediated dimerization.</PubMed_Title>
      <Author>Chantalat L, et al.</Author>
      <Journal>EMBO J. 1999 Jun 1;18(11):2930-40.</Journal>
      <PubMed_ID>10357806</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DIMERIC CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT IN COMPLEX WITH TWO BETA PEPTIDES MIMICKING THE ARCHITECTURE OF THE TETRAMERIC PROTEIN KINASE CK2 HOLOENZYME.</PDB_Title>
      <PDB_ID>1DS5</PDB_ID>
      <Resolution>3.16</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DS5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The crystal structure of the complex of Zea mays alpha subunit with a fragment of human beta subunit provides the clue to the architecture of protein kinase CK2 holoenzyme.</PubMed_Title>
      <Author>Battistutta R, et al.</Author>
      <Journal>Eur J Biochem. 2000 Aug;267(16):5184-90.</Journal>
      <PubMed_ID>10931203</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human protein kinase CK2 regulatory subunit (CK2beta; mutant 1-193)</PDB_Title>
      <PDB_ID>3EED</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3EED</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The interaction of CK2alpha and CK2beta, the subunits of protein kinase CK2, requires CK2beta in a preformed conformation and is enthalpically driven.</PubMed_Title>
      <Author>Raaf J, et al.</Author>
      <Journal>Protein Sci. 2008 Dec;17(12):2180-6.</Journal>
      <PubMed_ID>18824508</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04520</Pathway_ID>
      <Pathway_Title>Adherens junction</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05168</Pathway_ID>
      <Pathway_Title>Herpes simplex infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04310</Pathway_ID>
      <Pathway_Title>Wnt signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05169</Pathway_ID>
      <Pathway_Title>Epstein-Barr virus infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05168</Pathway_ID>
      <Pathway_Title>Herpes simplex infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04530</Pathway_ID>
      <Pathway_Title>Tight junction</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04712</Pathway_ID>
      <Pathway_Title>Circadian rhythm - plant</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Environmental adaptation</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04064</Pathway_ID>
      <Pathway_Title>NF-kappa B signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05162</Pathway_ID>
      <Pathway_Title>Measles</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04712</Pathway_ID>
      <Pathway_Title>Circadian rhythm - plant</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Environmental adaptation</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Small proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.h.fh.f.b.b.html</SCOP_URL>
    <CATH_Class>Mainly alpha@@Mainly beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1qf8@@http://www.cathdb.info/pdb/1qf8</CATH_URL>
  </Fold>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>2.7.11.1</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/7/11/1.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00510001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00510002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00510003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00510004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00510005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>